About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Phoenix | 8,250 Studies Near You

Clinical TrialsPhoenix

Clinical Trials in Phoenix

Discover 8,250 clinical trials near Phoenix, Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3261-3280 of 8,250 trials

RecruitingA Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)This phase II trial tests effects of nivolumab in combination with chemotherapy drugs prior to radiation therapy patients with nasopharyngeal carcinoma (NPC).NCT06064097·Birmingham, Alabama and 85 others

Find Trials by Condition in Phoenix

Breast Cancerin Phoenix Lung Cancerin Phoenix Prostate Cancerin Phoenix Colorectal Cancerin Phoenix Melanomain Phoenix Leukemiain Phoenix Lymphomain Phoenix Pancreatic Cancerin Phoenix Ovarian Cancerin Phoenix Brain Cancerin Phoenix Diabetes

Data from ClinicalTrials.govTerms

CompletedEssure (Model ESS310) Placement Rate StudyTo evaluate the safety and successful placement rate of Essure Model ESS310 device and any factors that may influence the successful placement rate of this device.NCT02064413·Glendale, Arizona and 15 others

CompletedFactors Affecting Adherence to Anti-HIV Drug Regimens in Children and AdolescentsTaking anti-HIV medication consistently and properly is a critical issue for patients with HIV.NCT00073424·Birmingham, Alabama and 35 others

CompletedComparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid ArthritisDemonstrate equivalent efficacy of GP2015 and EU-authorized Enbrel in patients with moderate to severe, active (RA) who had an inadequate response to disease modifying…NCT02638259·Peoria, Arizona and 91 others

Active not recruitingA Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisThe purpose of the study is to see how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo and deucravacitinib.NCT06143878·Phoenix, Arizona and 163 others

CompletedRadicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)REFINE-ALS is a prospective, observational, longitudinal, multicenter study designed to identify biomarkers to serve as quantifiable biological non-clinical measures of Edaravone…NCT04259255·Phoenix, Arizona and 19 others

CompletedFollowing Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications ExistThis is a prospective observational cohort study that is in the process of enrolling and following patients on warfarin therapy by utilizing anticoagulation clinics in VA…NCT00075985·Phoenix, Arizona and 16 others

CompletedTo Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic DermatitisThis is a Phase II, randomized, double-blind, placebo-controlled study in subjects with moderate to severe atopic dermatitis.NCT04684485·Phoenix, Arizona and 57 others

Active not recruitingA Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Risdiplam (ASCEND)In this study, researchers will learn more about the use of a higher dose of nusinersen (BIIB058) in participants with spinal muscular atrophy (SMA).NCT05067790·Phoenix, Arizona and 21 others

CompletedEfficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 DiabetesThe aim of this study is to investigate the efficacy, safety and tolerability of BI 10773 compared to placebo and sitagliptin given for 24 weeks as monotherapy in patients with…NCT01177813·Mesa, Arizona and 123 others

CompletedA Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic CancerThis is a 2-phase study during which patients with advanced/metastatic solid tumors will receive investigational study drug ARRY-334543 and gemcitabine. The study has 2 parts.NCT00862524·Phoenix, Arizona and 5 others

CompletedA Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic CancerThis is an open label, multi-center, multi-arm, dose-escalation study of BBI608 administered in combination with Gemcitabine and nab-Paclitaxel, mFOLFIRINOX, FOLFIRI, or MM-398…NCT02231723·Phoenix, Arizona and 11 others

Active not recruitingMirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal CancerGLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants…NCT05445778·Mobile, Alabama and 263 others

TerminatedA Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe DiseaseThe objective of this study was to evaluate the efficacy and safety of treatment with 4000 litre (L) alglucosidase alfa (Lumizyme®) in Pompe participants.NCT01526785·Birmingham, Alabama and 50 others

CompletedTreatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting EnvenomationThis treatment protocol will enable therapeutic use of Anascorp in the management of systemic manifestations of scorpion sting envenomation, in patients for whom antivenom would…NCT00624078·Casa Grande, Arizona and 17 others

CompletedA Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.This is a multi-center, randomized, double-blind, placebo-controlled, parallel group 36 week multicenter Phase 2 study of two doses of CT1812 in adults with mild to moderate…NCT03507790·Phoenix, Arizona and 31 others

CompletedPaclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian CancerPhase I trial to study the effectiveness of paclitaxel, cisplatin, and topotecan with or without filgrastim in treating patients who have newly diagnosed stage III or stage IV…NCT00002913·Phoenix, Arizona

Approved for marketingAztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway InfectionThe primary objective of this program is to provide expanded access to aztreonam lysine for inhalation (AZLI) 75 mg prior to its commercial availability to patients with cystic…NCT00499720·Birmingham, Alabama and 64 others

CompletedCo-administration of Olodaterol Respimat® and Tiotropium Handihaler®The overall objective of this study is to assess efficacy and safety of 12 weeks, once daily, orally inhaled co-administration of olodaterol 5 µg (delivered by the Respimat®…NCT01696058·Anniston, Alabama and 93 others

CompletedFeasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ TreatmentThis study will evaluate the efficacy of a lidocaine topical anesthetic (numbing cream) for reducing discomfort associated with Ultherapy™ treatment.NCT01708447·Phoenix, Arizona

PreviousPage 164 of 413Next

in Phoenix

Heart Diseasein Phoenix